Literature DB >> 7543366

Anti-angiogenic activity of triterpene acids.

K H Sohn1, H Y Lee, H Y Chung, H S Young, S Y Yi, K W Kim.   

Abstract

Ursolic acid (UA) and oleanolic acid (OA) were examined for anti-angiogenic activities by using the chick embryo chorioallantoic membrane (CAM) assay. The presence of UA or OA inhibited angiogenesis in a dose-dependent manner; the doses required for half-maximal inhibition (ID50) were 5 micrograms and 40 micrograms per CAM, respectively. UA was a more potent angiogenic inhibitor than OA. We also tested for inhibitory effect on the proliferation of bovine aortic endothelial cell. They effectively inhibited the proliferation of bovine aortic endothelial cell in a concentration-dependent manner. The IC50 values of anti-proliferative effects were determined to be 5 microM for UA and 20 microM for OA. Based on these results, we speculated that the inhibitory effects on bovine aortic endothelial cell proliferation of UA and OA might be important for anti-angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543366     DOI: 10.1016/0304-3835(95)03856-r

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 2.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

Review 3.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

4.  Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.

Authors:  Rui-Xin Lin; Lu-Lu Gong; Li-Mei Fan; Zhong-Kai Zhao; Shu-Li Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells.

Authors:  Jing-song Wang; Tian-nian Ren; Tao Xi
Journal:  Med Oncol       Date:  2010-12-30       Impact factor: 3.064

6.  Inhibition of cell surface expression of endothelial adhesion molecules by ursolic acid prevents intimal hyperplasia of venous bypass grafts in rats.

Authors:  Iris Zeller; Dominik Wiedemann; Stefan Schwaiger; Marlies Stelzmüller; Simone Kreutmayer; Oliver Leberfing; Hermann Stuppner; David Bernhard
Journal:  Eur J Cardiothorac Surg       Date:  2012-05-02       Impact factor: 4.191

7.  Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications.

Authors:  Daniel Crístian Ferreira Soares; Diogo Coelho de Paula Oliveira; Luciola Silva Barcelos; Alan Sales Barbosa; Lorena Carla Vieira; Danyelle M Townsend; Domenico Rubello; André Luis Branco de Barros; Lucienir Pains Duarte; Armando Silva-Cunha
Journal:  Biomed Pharmacother       Date:  2017-05-27       Impact factor: 6.529

8.  Differential effects of several phytochemicals and their derivatives on murine keratinocytes in vitro and in vivo: implications for skin cancer prevention.

Authors:  Magdalena C Kowalczyk; Zbigniew Walaszek; Piotr Kowalczyk; Tatsuya Kinjo; Margaret Hanausek; Thomas J Slaga
Journal:  Carcinogenesis       Date:  2009-03-27       Impact factor: 4.944

9.  Anticancer effect of ursolic acid stearoyl glucoside in chemically induced hepatocellular carcinoma.

Authors:  Imran Kazmi; Anil Raj Narooka; Muhammad Afzal; Rajbala Singh; Fahad A Al-Abbasi; Aftab Ahmad; Firoz Anwar
Journal:  J Physiol Biochem       Date:  2013-03-20       Impact factor: 4.158

10.  Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivo.

Authors:  Christian M Strüh; Sebastian Jäger; Astrid Kersten; Christoph M Schempp; Armin Scheffler; Stefan F Martin
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.